Rex Health Ventures, which is managed by a community non-profit hospital, has invested $500,000 in Aerial Biopharma, a US-based narcolepsy treatment company.
Aerial was formed in January 2011 by a team of biopharmaceutical entrepreneurs. Aerial’s investigational narcolepsy treatment is in Phase 2 clinical trials.
Rex President David Strong said: “This is precisely why we created Rex Health Ventures and Rex Strategic Innovations: to find and support promising companies with exciting products that could improve the lives of thousands of patients.…
